Integrating clinical rare cell enrichment, culture, and single-cell phenotypic profiling is
currently hampered by the lack of competent technologies, which typically suffer from weak …

As “liquid biopsies”, circulating tumor cells (CTCs) have been thought to hold significant
insights for cancer diagnosis and treatment. Despite the advances of microfluidic techniques …

The topographic features at the cell–material biointerface are critical for cellular sensing of
the extracellular environment (ECM) and have gradually been recognized as key factors that …

The ubiquitous biomembrane interface, with its dynamic lateral fluidity, allows membrane-
bound components to rearrange and localize for high-affinity multivalent ligand–receptor …

Cell analysis often requires the isolation of certain cell types. Various isolation methods
have been applied to cell sorting, including florescence-activated cell sorting and magnetic …

Circulating tumor cells (CTCs), as important liquid biopsy target, can provide valuable
information for cancer progress monitoring and individualized treatment. However, current …

Here we presented a simple and effective membrane mimetic microfluidic device with
antibody conjugated supported lipid bilayer (SLB)“smart coating” to capture viable …

The recovery of rare single circulating tumor cells (CTCs) from patients has great potential to
facilitate the study of cell heterogeneity and cancer metastasis, which may promote the …

Circulating tumor cells (CTCs) in blood is the direct cause of tumor metastasis. The isolation
and detection of CTCs in the whole blood is very important and of clinical value in early …

Cancer cells metastasize and are transported in the bloodstream, easily reaching any site in
the body through the blood circulation. A method designed to assess the number of …